WINTON GROUP Ltd - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 194 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$81,855
+132.9%
109,140
+14.4%
0.01%
+150.0%
Q4 2022$35,153
-7.5%
95,394
+6.8%
0.00%0.0%
Q3 2022$38,000
-49.3%
89,346
-7.5%
0.00%
-50.0%
Q2 2022$75,000
+114.3%
96,571
+256.1%
0.00%
+100.0%
Q1 2022$35,000
-25.5%
27,119
+111.4%
0.00%
+100.0%
Q4 2019$47,000
-63.6%
12,829
-12.7%
0.00%
-66.7%
Q4 2018$129,000
-57.6%
14,703
+1.5%
0.00%
-62.5%
Q2 2018$304,000
-3.2%
14,487
-25.7%
0.01%
-11.1%
Q1 2018$314,000
-90.4%
19,487
-91.6%
0.01%
-91.3%
Q3 2017$3,263,000231,9470.10%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,383,466$139,917,00012.64%
ASHFORD CAPITAL MANAGEMENT INC 362,615$6,872,0001.07%
NEXTHERA CAPITAL LP 259,300$4,914,0000.91%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 639,856$12,125,0000.89%
Sonora Investment Management, LLC 249,502$4,728,063,0000.76%
Kazazian Asset Management, LLC 32,526$616,0000.63%
Piermont Capital Management Inc. 88,372$1,675,0000.55%
J. Goldman & Co LP 266,479$5,050,0000.26%
J. Goldman & Co LP 251,500$4,766,0000.25%
Opaleye Management Inc. 31,000$587,0000.19%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders